This has also been reported when evaluating the cell surface marker CD10, where loss has been documented at the DCIS stage [9, 29, 30], limiting the ability to immunopurify myoepithelial cells from fresh DCIS tissues. Here, MME is linked to ductal breast carcinoma in situ.